首页> 外文期刊>Biochemical and Biophysical Research Communications >Cross-sensitization between xeno- and allo-antigens on subsequent allogeneic and xenogeneic pancreatic islet transplantation in a murine model
【24h】

Cross-sensitization between xeno- and allo-antigens on subsequent allogeneic and xenogeneic pancreatic islet transplantation in a murine model

机译:异源和同种异源抗原在鼠模型中随后异基因和异源胰腺胰岛移植的交叉致敏

获取原文
获取原文并翻译 | 示例
           

摘要

The number of patients in need of organ transplantation is continuously on the rise. However, because of organ donor shortage, xenotransplantation has been highlighted as an alternative. Among the various porcine organs and tissues, porcine islets are considered to be the best-matching implantable candidates for clinical application based on recent progress in nonhuman primate pre-clinical studies. Nevertheless, before initiation of clinical trials, it should be confirmed whether the requisite xeno-antigen sensitization would have a deleterious effect on subsequent allo-transplantation or vice versa. Therefore, in the present study, the survival rate of islets grafted in naive recipients was compared with that in cross sensitized recipients. Enzyme-linked immunosorbent spot, fluorescence-activated cell sorting, and immunohistochemistry were conducted to assess the cellular and humoral immune responses. The survival days of Balb/c mouse islets transplanted into B6 mice that had been previously sensitized with porcine cells (i.e., xeno-sensitized) showed no significant difference from that of na ve B6 mice. Moreover, the survival days of porcine islets transplanted into allo-antigen (Balb/c)-sensitized B6 recipients was not significantly different from that in na ve B6 mice. Furthermore, our data provide the first demonstration that the cellular xenogeneic immune response (against porcine antigen) measured by an enzyme-linked immunosorbent spot assay is not cross-reactive to the allogeneic immune responses in a murine islet transplantation model. These results suggest that clinical application of islet xenotransplantation is not likely to have a deleterious effect on subsequent allogeneic islet transplantation. (C) 2016 Elsevier Inc. All rights reserved.
机译:需要器官移植的患者数量持续增加。然而,由于器官供体的短缺,异种移植已成为一种替代方法。根据非人类灵长类动物临床前研究的最新进展,在各种猪器官和组织中,猪胰岛被认为是临床应用中最匹配的可植入候选物。然而,在开始临床试验之前,应确认必要的异种抗原敏化是否会对随后的同种异体移植产生有害影响,反之亦然。因此,在本研究中,将天真受体移植的胰岛存活率与交叉致敏受体的胰岛存活率进行了比较。进行酶联免疫吸附点,荧光激活细胞分选和免疫组织化学以评估细胞和体液免疫反应。将Balb / c小鼠胰岛移植到先前已用猪细胞敏化(即异种敏化)的B6小鼠中的存活天数与单纯B6小鼠的存活天数没有显着差异。此外,移植到同种抗原(Balb / c)致敏的B6受体中的猪胰岛的存活天数与单纯B6小鼠的存活天数没有显着差异。此外,我们的数据提供了第一个证明,即通过酶联免疫吸附斑点测定法测量的细胞异种免疫应答(针对猪抗原)与鼠胰岛移植模型中的同种异体免疫应答没有交叉反应。这些结果表明,胰岛异种移植的临床应用不太可能对随后的同种异体胰岛移植产生有害作用。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号